Nitta Gelatin India Ltd

₹ 858 3.46%

17 Apr - close price

About

Incorporated in 1975, Nitta Gelatin India Ltd manufactures and sells ossein, gelatin, and collagen peptide^[1]

Key Points

Business Overview:^[1]
NGIL, a joint venture between the Kerala State Industrial Development Corporation (32% shareholding) and Osaka-based NGI (43% stake), manufactures gelatin, ossein, limed ossein, and DCP from processed animal bones. It also produces collagen peptide-based consumer products for the pharmaceutical and healthcare industries.

Website BSE

Market Cap ₹ 779 Cr.
Current Price ₹ 858
High / Low ₹ 1,005 / 735
Stock P/E 8.38
Book Value ₹ 474
Dividend Yield 0.70 %
ROCE 25.7 %
ROE 20.7 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company has delivered good profit growth of 56.1% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
	119	130	116	123	118	115	131	132	135	129	139	138	150
	89	107	82	97	91	93	104	107	108	106	111	112	112
Operating Profit	31	23	34	27	27	22	28	25	27	23	27	26	38
OPM %	26%	17%	29%	22%	23%	19%	21%	19%	20%	18%	20%	19%	25%
	0	0	2	9	0	5	2	4	9	6	2	11	7
Interest	1	0	0	0	0	2	0	0	1	1	1	1	0
Depreciation	3	3	3	4	4	4	3	3	3	3	3	4	4
Profit before tax	27	19	33	32	23	22	26	26	32	26	26	33	41
Tax %	22%	28%	25%	21%	29%	26%	26%	25%	25%	25%	25%	20%	23%
	21	14	24	25	17	16	19	20	24	19	19	26	31
EPS in Rs	22.85	15.23	26.97	27.63	18.29	17.94	21.19	21.51	26.73	21.11	21.35	28.79	34.21
Raw PDF

Upcoming result date: 2 May 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	287	355	357	341	343	261	294	354	429	487	473	527	556
	277	329	318	304	316	243	268	314	378	397	363	424	442
Operating Profit	10	27	39	37	27	18	27	40	51	90	110	104	114
OPM %	3%	8%	11%	11%	8%	7%	9%	11%	12%	18%	23%	20%	21%
	0	2	2	9	5	1	3	5	6	5	17	22	27
Interest	6	8	6	4	7	8	8	5	5	4	3	3	2
Depreciation	11	10	9	10	14	14	15	15	14	13	14	13	14
Profit before tax	-7	10	26	32	11	-4	7	24	38	78	110	110	125
Tax %	-32%	49%	37%	36%	65%	-28%	-15%	26%	29%	25%	25%	25%
	-5	5	17	20	4	-3	8	18	27	59	82	82	96
EPS in Rs	-5.46	5.62	18.38	22.57	4.16	-2.91	8.70	19.72	29.30	64.72	90.86	90.55	105.46
Dividend Payout %	0%	18%	14%	11%	60%	-52%	29%	15%	14%	12%	7%	9%

Compounded Sales Growth
10 Years:	4%
5 Years:	12%
3 Years:	7%
TTM:	8%

Compounded Profit Growth
10 Years:	30%
5 Years:	56%
3 Years:	40%
TTM:	25%

Stock Price CAGR
10 Years:	15%
5 Years:	40%
3 Years:	1%
1 Year:	15%

Return on Equity
10 Years:	16%
5 Years:	22%
3 Years:	25%
Last Year:	21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	9	9	9	9	9	9	9	9	9	9	9	9	9
Reserves	106	113	125	130	138	133	134	154	176	231	307	383	421
	53	53	70	84	104	101	79	75	80	33	27	45	36
	42	40	45	48	55	51	53	49	51	53	57	54	62
Total Liabilities	210	214	249	271	305	295	276	287	316	326	400	492	528
	82	77	80	77	110	126	116	108	102	109	106	111	144
CWIP	8	8	7	11	10	3	4	2	7	7	8	19	5
Investments	32	32	45	27	4	4	4	4	4	5	5	5	5
	88	96	117	157	181	161	151	172	202	206	281	357	375
Total Assets	210	214	249	271	305	295	276	287	316	326	400	492	528

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	23	17	29	11	26	28	33	15	13	78	79	61
	-24	-8	-22	-3	-7	-13	-7	-3	-11	-15	-44	2
	0	-8	11	-6	-20	-14	-29	-12	-2	-53	-15	11
Net Cash Flow	-0	1	18	2	-0	1	-3	-0	-1	10	20	74
Free Cash Flow	-1	8	18	-4	12	12	24	8	-1	58	67	37
CFO/OP	259%	73%	88%	51%	138%	165%	133%	49%	26%	109%	97%	83%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	28	23	21	56	65	74	34	57	65	59	60	66
Inventory Days	129	99	112	127	151	202	220	161	148	133	164	138
Days Payable	80	50	43	37	56	67	58	46	30	45	53	38
Cash Conversion Cycle	77	72	90	147	160	210	196	172	182	148	171	165
Working Capital Days	6	17	18	35	29	18	18	50	52	72	82	75
ROCE %	-1%	11%	17%	17%	7%	2%	6%	13%	17%	31%	37%	26%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Export Share of Gelatin Sales
%

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx
xx.xx	xx.xx			xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
x,xxx	x,xxx	x,xxx	x,xxx		x,xxx				x,xxx	x,xxx
										x,xxx
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx

Please log in to see hidden values.

Production Volume - Di-Calcium Phosphate (DCP) (Subsidiaries)
MT

Production Volume - Ossein (Subsidiaries)
MT

Export Share of Collagen Peptide Sales
%

Installed Capacity - Gelatin
MT per year

Gelatin Capacity Expansion Announced
MT

R&D Expenditure (Percentage of Turnover)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%	74.49%
	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.26%	0.12%	0.12%	0.12%	0.12%	0.12%	0.08%	0.09%	0.35%	0.64%	0.75%	0.93%
	25.26%	25.41%	25.40%	25.40%	25.39%	25.40%	25.45%	25.43%	25.17%	24.89%	24.76%	24.59%
No. of Shareholders	8,466	10,183	11,028	11,573	11,783	12,229	12,239	12,078	11,574	11,248	10,881	10,551

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	74.48%	74.48%	74.48%	74.48%	74.48%	74.48%	74.49%	74.49%	74.49%	74.49%
	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	0.26%	0.12%	0.09%	0.93%
	25.40%	25.40%	25.40%	25.40%	25.40%	25.40%	25.26%	25.40%	25.43%	24.59%
No. of Shareholders	6,420	6,037	5,887	5,774	5,898	6,375	8,332	11,573	12,078	10,551

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Nitta Gelatin India Ltd

Nitta Gelatin India Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings